← All Sponsors
SPONSOR

Dyne Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Myotonic Dystrophy Type 1 (DM1)
NCT05481879 Phase 1, Phase 2
Recruiting

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

Myotonic Dystrophy Type 1 (DM1)
United States, Australia, France View Trial →